SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound healing, today announced the publication of...

For years now, scientists have tried to develop a safe and effective dengue vaccine. The challenge however, is that there are four different types of...

CHATHAM, N.J., July 09, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, today...

The US Advisory Committee on Immunization Practices voted in June to stop recommending certain kinds of flu vaccines, a notable shift in vaccine...

The US Advisory Committee on Immunization Practices voted in June to stop recommending certain kinds of flu vaccines, a notable shift in vaccine...

Researchers at Burnet Institute, in collaboration with Gavi, the Vaccine Alliance, have provided the world’s first ever look at the historical...

MRNA's mRNA-1010 flu vaccine outperforms GSK's shot by 26.6% in a large phase III trial of adults 50 and older.

A new study from the University of Oxford has revealed a surprising benefit of the respiratory syncytial virus (RSV) vaccine: it may reduce the risk...

ISOThrive Inc. announced promising Phase 2 interim data for ISOT-101, a novel NERD treatment for PPI partial-responders. Pharma veteran Mike Walther...

The study looked at vaccines deployed during outbreaks of five deadly diseases....